Surfactant protein A activation of atypical protein kinase C ζ in IκB-α-dependent anti-inflammatory immune regulation

Journal of Immunology

Volumn 179, Issue 7, 2007, Pages 4480-4491

  Moulakakis, Christina ^a   Adam, Stefanie ^a   Seitzer, Ulrike ^a   Schromm, Andra B ^a   Leitges, Michael ^b   Stamme, Cordula ^a,c,d  

^a Leibniz Centers for Medicine and Biosciences   (Germany)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d Centre for Research Borstel   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B ALPHA; I KAPPA B BETA; LIPOPOLYSACCHARIDE; PROTEIN KINASE C ZETA; SURFACTANT PROTEIN A; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; IMMUNOPRECIPITATION; IMMUNOREGULATION; LUNG ALVEOLUS MACROPHAGE; MALE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; RAT;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL MEMBRANE; CELLS, CULTURED; ENZYME ACTIVATION; I-KAPPA B KINASE; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, TRANSGENIC; MUTATION; NF-KAPPA B; PHOSPHOTHREONINE; PROTEIN BINDING; PROTEIN KINASE C; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 48749088893     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.7.4480     Document Type: Article

References (61)

1. McCormack, F. X., and J. A. Whitsett. 2002. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J. Clin. Invest. 109: 707-712.
2. Wright, J. R. 2005. Immunoregulatory functions of surfactant proteins. Nat. Rev. Immunol. 5: 58-68.
3. Shepherd, V. L. 2002. Distinct roles for lung collectins in pulmonary host defense. Am. J. Respir. Cell Mol. Biol. 26: 257-260.
4. Levine, A. M., and J. A. Whitsett. 2001. Pulmonary collectins and innate host defense of the lung. Microbes Infect. 3: 161-166.
5. Borron, P., J. C. McIntosh, T. R. Korfhagen, J. A. Whitsett, J. Taylor, and J. R. Wright. 2000. Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. Am. J. Physiol. 278: L840-L847.
6. Monick, M. M., and G. W. Hunninghake. 2002. Activation of second messenger pathways in alveolar macrophages by endotoxin. Eur. Respir. J. 20: 210-222.
7. Van de Wetering, J. K., L. M. van Golde, and J. J. Batenburg. 2004. Collectins: players of the innate immune system. Eur. J. Biochem. 271: 1229-1249.
8. Piantadosi, C. A., and D. A. Schwartz. 2004. The acute respiratory distress syndrome. Ann. Intern. Med. 141: 460-470.
9. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, H. C. Van, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088.
10. Shimazu, R., S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, K. Miyake, and M. Kimoto. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189: 1777-1782.
11. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
12. Pando, M. P., and I. M. Verma. 2000. Signal-dependent and -independent degradation of free and NF-κB-bound IκBα. J. Biol. Chem. 275: 21278-21286.
13. Tergaonkar, V., R. G. Correa, M. Ikawa, and I. M. Verma. 2005. Distinct roles of IκB proteins in regulating constitutive NF-κB activity. Nat. Cell Biol. 7: 921-923.
14. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science 267: 1485-1488.
15. Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-κB puzzle. Cell 109 (Suppl. 1): S81-S96.
16. Brown, K., S. Park, T. Kanno, G. Franzoso, and U. Siebenlist. 1993. Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκB-α. Proc. Natl. Acad. Sci. USA 90: 2532-2536.
17. Chen, L. F., and W. C. Greene. 2004. Shaping the nuclear action of NF-κB. Nat. Rev. Mol. Cell Biol. 5: 392-401.
18. McIntosh, J. C., S. Mervin-Blake, E. Conner, and J. R. Wright. 1996. Surfactant protein A protects growing cells and reduces TNF-α activity from LPS-stimulated macrophages. Am. J. Physiol. 271: L310-L319.
19. Sano, H., H. Sohma, T. Muta, S. Nomura, D. R. Voelker, and Y. Kuroki. 1999. Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14. J. Immunol. 163: 387-395.
20. Gardai, S. J., Y. Q. Xiao, M. Dickinson, J. A. Nick, D. R. Voelker, K. E. Greene, and P. M. Henson. 2003. By binding SIRPα or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 115: 13-23.
21. Garcia-Verdugo, I., F. Sanchez-Barbero, K. Soldau, P. S. Tobias, and C. Casals. 2005. Interaction of SP-A (surfactant protein A) with bacterial rough lipopolysaccharide (Re-LPS), and effects of SP-A on the binding of Re-LPS to CD14 and LPS-binding protein. Biochem. J. 391: 115-124.
22. Stamme, C., E. Walsh, and J. R. Wright. 2000. Surfactant protein A differentially regulates IFN-γ- and LPS-induced nitrite production by rat alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 23: 772-779.
23. Alcorn, J. F., and J. R. Wright. 2004. Surfactant protein A inhibits alveolar macrophage cytokine production by CD14-independent pathway. Am. J. Physiol. 286: L129-L136.
24. Wu, Y., S. Adam, L. Hamann, H. Heine, A. J. Ulmer, U. Buwitt-Beckmann, and C. Stamme. 2004. Accumulation of inhibitory κB-α as a mechanism contributing to the anti-inflammatory effects of surfactant protein-A. Am. J. Respir. Cell Mol. Biol. 31: 587-594.
25. Crowther, J. E., V. K. Kutala, P. Kuppusamy, J. S. Ferguson, A. A. Beharka, J. L. Zweier, F. X. McCormack, and L. S. Schlesinger. 2004. Pulmonary surfactant protein A inhibits macrophage reactive oxygen intermediate production in response to stimuli by reducing NADPH oxidase activity. J. Immunol. 172: 6866-6874.
26. Schagat, T. L., M. J. Tino, and J. R. Wright. 1999. Regulation of protein phosphorylation and pathogen phagocytosis by surfactant protein A. Infect. Immun. 67: 4693-4699.
27. Bren, G. D., K. N. Pennington, and C. V. Paya. 2000. PKC-ζ- associated CK2 participates in the turnover of free IκBα. J. Mol. Biol. 297: 1245-1258.
28. Moscat, J., and M. T. Diaz-Meco. 2000. The atypical protein kinase Cs: functional specificity mediated by specific protein adapters. EMBO Rep. 1: 399-403.
29. Tan, S. L., and P. J. Parker. 2003. Emerging and diverse roles of protein kinase C in immune cell signalling. Biochem. J. 376: 545-552.
30. Hirai, T., and K. Chida. 2003. Protein kinase Cζ (PKCζ): activation mechanisms and cellular functions. J. Biochem. 133: 1-7.
31. Le Good, J. A., and D. N. Brindley. 2004. Molecular mechanisms regulating protein kinase Cζ turnover and cellular transformation. Biochem. J. 378: 83-92.
32. Cheng, J. D., R. P. Ryseck, R. M. Attar, D. Dambach, and R. Bravo. 1998. Functional redundancy of the nuclear factor κB inhibitors IκBα and IκBβ. J. Exp. Med. 188: 1055-1062.
33. Leitges, M., L. Sanz, P. Martin, A. Duran, U. Braun, J. F. Garcia, F. Camacho, M. T. Diaz-Meco, P. D. Rennert, and J. Moscat. 2001. Targeted disruption of the ζPKC gene results in the impairment of the NF-κB pathway. Mol. Cell 8: 771-780.
34. Kovac, J., H. Oster, and M. Leitges. 2007. Expression of the atypical protein kinase C (aPKC) isoforms ι/γ and ζ during mouse embryogenesis. Gene Expr. Patterns 7: 187-196.
35. r = 26,000 -36,000 enhances uptake of liposomes by type II cells. J. Biol. Chem. 262: 2888-2894.
36. Beg, A. A., W. C. Sha, R. T. Bronson, and D. Baltimore. 1995. Constitutive NF-κB activation, enhanced granulopoiesis, and neonatal lethality in IκBα-deficient mice. Genes Dev. 9: 2736-2746.
37. Fan, C., Q. Li, Y. Zhang, X. Liu, M. Luo, D. Abbott, W. Zhou, and J. F. Engelhardt. 2004. IκBα and IκBβ possess injury context-specific functions that uniquely influence hepatic NF-κB induction and inflammation. J. Clin. Invest. 113: 746-755.
38. Beharka, A. A., J. E. Crowther, F. X. McCormack, G. M. Denning, J. Lees, E. Tibesar, and L. S. Schlesinger. 2005. Pulmonary surfactant protein A activates a phosphatidylinositol 3-kinase/calcium signal transduction pathway in human macrophages: participation in the up-regulation of mannose receptor activity. J. Immunol. 175: 2227-2236.
39. Guha, M., and N. Mackman. 2002. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J. Biol. Chem. 277: 32124-32132.
40. Standaert, M. L., L. Galloway, P. Karnam, G. Bandyopadhyay, J. Moscat, and R. V. Farese. 1997. Protein kinase C-ζ as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes: potential role in glucose transport. J. Biol. Chem. 272: 30075-30082.
41. Le Good, J. A., W. H. Ziegler, D. B. Parekh, D. R. Alessi, P. Cohen, and P. J. Parker. 1998. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281: 2042-2045.
42. Herrera-Velit, P., K. L. Knutson, and N. E. Reiner. 1997. Phosphatidylinositol 3-kinase-dependent activation of protein kinase C-ζ in bacterial lipopolysaccharide-treated human monocytes. J. Biol. Chem. 272: 16445-16452.
43. Chou, M. M., W. Hou, J. Johnson, L. K. Graham, M. H. Lee, C. S. Chen, A. C. Newton, B. S. Schaffhausen, and A. Toker. 1998. Regulation of protein kinase Cζ by PI 3-kinase and PDK-1. Curr. Biol. 8: 1069-1077.
44. Parekh, D. B., W. Ziegler, and P. J. Parker. 2000. Multiple pathways control protein kinase C phosphorylation. EMBO J. 19: 496-503.
45. Duran, A., M. T. Diaz-Meco, and J. Moscat. 2003. Essential role of RelA Ser311 phosphorylation by ζPKC in NF-κB transcriptional activation. EMBO J. 22: 3910-3918.
46. Soloff, R. S., C. Katayama, M. Y. Lin, J. R. Feramisco, and S. M. Hedrick. 2004. Targeted deletion of protein kinase Creveals a distribution of functions between the two atypical protein kinase C isoforms. J. Immunol. 173: 3250-3260.
47. Sano, H., H. Chiba, D. Iwaki, H. Sohma, D. R. Voelker, and Y. Kuroki. 2000. Surfactant proteins A and D bind CD14 by different mechanisms. J. Biol. Chem. 275: 22442-22451.
48. Stamme, C., M. Muller, L. Hamann, T. Gutsmann, and U. Seydel. 2002. Surfactant protein A inhibits lipopolysaccharide-induced immune cell activation by preventing the interaction of lipopolysaccharide with lipopolysaccharide- binding protein. Am. J. Respir. Cell Mol. Biol. 27: 353-360.
49. Janosch, P., M. Schellerer, T. Seitz, P. Reim, M. Eulitz, M. Brielmeier, W. Kolch, J. M. Sedivy, and H. Mischak. 1996. Characterization of IκB kinases: IκB-α is not phosphorylated by Raf-1 or protein kinase C isozymes, but is a casein kinase II substrate. J. Biol. Chem. 271: 13868-13874.
50. Scott, M. T., A. Ingram, and K. L. Ball. 2002. PDK1-dependent activation of atypical PKC leads to degradation of the p21 tumor modifier protein. EMBO J. 21: 6771-6780.
51. Hernandez-Pigeon, H., A. Quillet-Mary, T. Louat, A. Schambourg, O. Humbert, J. Selves, B. Salles, G. Laurent, and D. Lautier. 2005. hMutSα is protected from ubiquitin-proteasome-dependent degradation by atypical protein kinase Cζ phosphorylation. J. Mol. Biol. 348: 63-74.
52. Diaz-Meco, M. T., M. J. Lallena, A. Monjas, S. Frutos, and J. Moscat. 1999. Inactivation of the inhibitory κB protein kinase/nuclear factor κB pathway by Par-4 expression potentiates tumor necrosis factor α-induced apoptosis. J. Biol. Chem. 274: 19606-19612.
53. Lallena, M. J., M. T. Diaz-Meco, G. Bren, C. V. Paya, and J. Moscat. 1999. Activation of IκB kinase β by protein kinase C isoforms. Mol. Cell. Biol. 19: 2180-2188.
54. ras and protein kinase Cζ in primary endothelial cells. J. Biol. Chem. 274: 13594-13603.
55. Martin, P., R. Villares, S. Rodriguez-Mascarenhas, A. Zaballos, M. Leitges, J. Kovac, I. Sizing, P. Rennert, G. Marquez, A. Martinez, et al. 2005. Control of T helper 2 cell function and allergic airway inflammation by PKCζ. Proc. Natl. Acad. Sci. USA 102: 9866-9871.
56. Nakanishi, H., K. A. Brewer, and J. H. Exton. 1993. Activation of the ζ isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 268: 13-16.
57. Limatola, C., D. Schaap, W. H. Moolenaar, and W. J. van Blitterswijk. 1994. Phosphatidic acid activation of protein kinase C-ζ overexpressed in COS cells: comparison with other protein kinase C isotypes and other acidic lipids. Biochem. J. 304: 1001-1008.
58. Muller, G., M. Ayoub, P. Storz, J. Rennecke, D. Fabbro, and K. Pfizenmaier. 1995. PKCζ is a molecular switch in signal transduction of TNF-α, bifunctionally regulated by ceramide and arachidonic acid. EMBO J. 14: 1961-1969.
59. Procyk, K. J., M. R. Rippo, R. Testi, F. Hofmann, P. J. Parker, and M. Baccarini. 2000. Lipopolysaccharide induces jun N-terminal kinase activation in macrophages by a novel Cdc42/Rac-independent pathway involving sequential activation of protein kinase Cζ and phosphatidylcholine- dependent phospholipase C. Blood 96: 2592-2598.
60. Jaken, S., and P. J. Parker. 2000. Protein kinase C binding partners. BioEssays 22: 245-254.
61. 2 induces an imbalance between mitogen-activated protein kinases and NF-κB that promotes apoptosis in macrophages. Mol. Cell. Biol. 23: 1196-1208.